Newsletters

Quick data scan on federal contracts. Rethinking platform strategies.

8.30.19

5 min. Read

Novartis predicts Amazon DTx delivery. VR pain relief.

8.22.19

5 min. Read

Excerpts from the 4,400-word AliveCor Report.

8.15.19

3 min. Read

Samsung’s quiet CardioBand FDA clearance. HealthXL’s evidence report.

8.08.19

4 min. Read

CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.

8.01.19

5 min. Read

The case against Proteus-Otsuka’s digital med. AliveCor’s 6th CEO

7.25.19

4 min. Read

FDA Pre-Cert tested with Pear insomnia DTx.

7.18.19

7 min. Read

Germany passes DTx formulary, payment law. Outcomes over Exits?

7.11.19

6 min. Read

Livongo clients mostly small commercial pilots? FDA easing.

7.02.19

6 min. Read

Omada’s strategy. Boehringer invests in myopia DTx.

6.27.19

6 min. Read